Jude Onyia, the Chief Scientific Officer of $NBIX, sold 20,362 shares of the company on 07-02-2025 for an estimated $2,649,737. We received data on the trade from a recent SEC filing. This was a sale of approximately 52.7% of their shares of this class of stock. Following this trade, they now own 18,289 shares of this class of $NBIX stock.
$NBIX Insider Trading Activity
$NBIX insiders have traded $NBIX stock on the open market 48 times in the past 6 months. Of those trades, 0 have been purchases and 48 have been sales.
Here’s a breakdown of recent trading of $NBIX stock by insiders over the last 6 months:
- KEVIN CHARLES GORMAN has made 0 purchases and 6 sales selling 166,543 shares for an estimated $24,358,762.
- KYLE GANO (Chief Executive Officer) has made 0 purchases and 6 sales selling 70,079 shares for an estimated $9,848,055.
- WILLIAM H RASTETTER sold 30,000 shares for an estimated $3,305,952
- JUDE ONYIA (Chief Scientific Officer) has made 0 purchases and 4 sales selling 23,367 shares for an estimated $3,005,250.
- STEPHEN A SHERWIN sold 13,831 shares for an estimated $1,613,922
- MATT ABERNETHY (Chief Financial Officer) has made 0 purchases and 4 sales selling 4,821 shares for an estimated $610,967.
- EIRY ROBERTS (Chief Medical Officer) has made 0 purchases and 5 sales selling 4,655 shares for an estimated $596,752.
- DARIN LIPPOLDT (Chief Legal Officer) has made 0 purchases and 4 sales selling 4,345 shares for an estimated $553,852.
- ERIC BENEVICH (Chief Commercial Officer) has made 0 purchases and 4 sales selling 4,341 shares for an estimated $551,966.
- JULIE COOKE (Chief Human Resources Officer) has made 0 purchases and 5 sales selling 3,991 shares for an estimated $529,946.
- DAVID W. BOYER (Chief Corp. Affairs Officer) has made 0 purchases and 4 sales selling 3,589 shares for an estimated $460,056.
- INGRID DELAET (Chief Regulatory Officer) has made 0 purchases and 4 sales selling 2,516 shares for an estimated $329,268.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$NBIX Hedge Fund Activity
We have seen 247 institutional investors add shares of $NBIX stock to their portfolio, and 322 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DODGE & COX added 2,518,199 shares (+83.5%) to their portfolio in Q1 2025, for an estimated $278,512,809
- CITADEL ADVISORS LLC removed 1,649,081 shares (-65.0%) from their portfolio in Q1 2025, for an estimated $182,388,358
- JPMORGAN CHASE & CO added 1,299,812 shares (+94.8%) to their portfolio in Q1 2025, for an estimated $143,759,207
- DSM CAPITAL PARTNERS LLC removed 932,595 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $103,145,007
- AQR CAPITAL MANAGEMENT LLC removed 822,261 shares (-43.3%) from their portfolio in Q1 2025, for an estimated $90,942,066
- WELLINGTON MANAGEMENT GROUP LLP added 640,556 shares (+44.0%) to their portfolio in Q1 2025, for an estimated $70,845,493
- DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) added 627,000 shares (+72.7%) to their portfolio in Q1 2025, for an estimated $69,346,200
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$NBIX Analyst Ratings
Wall Street analysts have issued reports on $NBIX in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wedbush issued a "Outperform" rating on 05/06/2025
- RBC Capital issued a "Outperform" rating on 05/06/2025
- UBS issued a "Buy" rating on 05/06/2025
- Guggenheim issued a "Buy" rating on 05/06/2025
- H.C. Wainwright issued a "Buy" rating on 04/22/2025
- Morgan Stanley issued a "Overweight" rating on 02/04/2025
To track analyst ratings and price targets for $NBIX, check out Quiver Quantitative's $NBIX forecast page.
$NBIX Price Targets
Multiple analysts have issued price targets for $NBIX recently. We have seen 3 analysts offer price targets for $NBIX in the last 6 months, with a median target of $158.0.
Here are some recent targets:
- An analyst from Canaccord Genuity set a target price of $158.0 on 04/28/2025
- Andrew Fein from H.C. Wainwright set a target price of $168.0 on 04/22/2025
- An analyst from Morgan Stanley set a target price of $150.0 on 03/07/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
